MicroRNA-1226-3p has a tumor-promoting role in osteosarcoma

Yong Li1, Dai Song2, Ting An3

  • 1Department of Orthopedics, Sixth Medical Center of the PLA General Hospital, Beijing 100048, P.R. China.

Oncology Letters
|April 28, 2021
PubMed

Insights

MicroRNA (miRNA) miR-1226-3p promotes osteosarcoma cell growth. Inhibiting miR-1226-3p in bone cancer cells reduced proliferation and increased cell death, suggesting a new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is a common bone cancer in adolescents and young adults, accounting for 10% of solid tumors in this age group.
  • MicroRNA (miRNA) dysregulation is implicated in the molecular pathogenesis of osteosarcoma.

Purpose of the Study:

  • To investigate the role of a novel miRNA, miR-1226-3p, in osteosarcoma.
  • To determine the functional impact of miR-1226-3p on osteosarcoma cell proliferation and apoptosis.
  • To identify the molecular targets of miR-1226-3p in osteosarcoma.

Main Methods:

  • Transfection of human osteosarcoma SaOS-2 cells with miR-1226-3p mimics and antisense oligonucleotides.
  • Assessment of cell apoptosis using a dead cell apoptosis kit.
  • Analysis of TNF receptor-associated factor 3 (TRAF3) protein expression via western blotting.
  • Bioinformatics and clinical specimen analyses.

Main Results:

  • Higher miR-1226-3p expression levels correlated with reduced survival rates in osteosarcoma patients.
  • miR-1226-3p overexpression promoted proliferation in SaOS-2 cells.
  • Inhibition of miR-1226-3p decreased cell proliferation and increased apoptosis in SaOS-2 cells.
  • miR-1226-3p was found to target TRAF3 in osteosarcoma cells.

Conclusions:

  • miR-1226-3p plays a significant role in promoting osteosarcoma cell proliferation.
  • miR-1226-3p may serve as a potential therapeutic target for osteosarcoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K